Sequent Extended Study
NCT: NCT05788432 · RECRUITING
NCT IDNCT05788432
StatusRECRUITING
Start Date2023-03-28
Completion2026-07-01
Brief Summary
Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Sequent Please Neo to meet EU Medical Device regulation (MDR) requirements in all the consecutive patients treated with Sequent Please Neo.
Frequently Asked Questions
What is Sequent Extended Study?
Sequent Extended Study is a clinical trial registered under NCT05788432. Current status: RECRUITING.
What is the status of NCT05788432?
The current status of NCT05788432 (Sequent Extended Study) is: RECRUITING.
When did Sequent Extended Study start?
Sequent Extended Study started on 2023-03-28.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.